UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patchouli Alcohol Possesses Anti‐Inflammatory Activity in RAW264.7 and HT‐29 cells

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Role of rice cytosolic hexokinase OsHXK7 in sugar signaling and metabolism

Journal of integrative plant biology, 2016-02, Vol.58 (2), p.127-135

2016

Volltextzugriff (PDF)

Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone

Journal of diabetes investigation, 2021-07, Vol.12 (7), p.1272-1277

2021

Volltextzugriff (PDF)

Splenic devascularization can replace splenectomy during adult living donor liver transplantation – a historical cohort study

Transplant international, 2019-05, Vol.32 (5), p.535-545

2019

Volltextzugriff (PDF)

An analysis of vascular properties using pulse wave analysis in patients with vasovagal syncope

Clinical cardiology (Mahwah, N.J.), 2020-07, Vol.43 (7), p.781-788

2020

Volltextzugriff (PDF)

Mechanical and Pharmacological Revascularization Strategies for Prevention of Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction: Analysis from Index of Microcirculatory Resistance Registry Data

Journal of interventional cardiology, 2020, Vol.2020 (2020), p.1-12

2020

Volltextzugriff (PDF)

Effect of switching from pioglitazone to the sodium glucose co‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus: An open‐label, prospective, randomized, parallel‐group comparison trial

Diabetes, obesity & metabolism, 2019-03, Vol.21 (3), p.710-714

2019

Volltextzugriff (PDF)

Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification

World journal of surgery, 2017-05, Vol.41 (5), p.1347-1357

2017

Volltextzugriff (PDF)

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial

Journal of diabetes investigation, 2019-05, Vol.10 (3), p.699-705

2019

Volltextzugriff (PDF)

Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)

Diabetes, obesity & metabolism, 2020-03, Vol.22 (3), p.458-462

2020

Volltextzugriff (PDF)

Splenic devascularization can replace splenectomy during adult living donor liver transplantation – a historical cohort study

Transplant international, 2019-05, Vol.32 (5), p.535-545

2019

Volltextzugriff (PDF)

Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes

Journal of diabetes investigation, 2021-02, Vol.12 (2), p.176-183

2021

Volltextzugriff (PDF)

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea

Journal of diabetes investigation, 2019-03, Vol.10 (2), p.367-374

2019

Volltextzugriff (PDF)

Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial

Journal of diabetes investigation, 2018-01, Vol.9 (1), p.119-126

2018

Volltextzugriff (PDF)

Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin

Journal of diabetes investigation, 2021-08, Vol.12 (8), p.1395-1399

2021

Volltextzugriff (PDF)

Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study

Journal of diabetes investigation, 2021-08, Vol.12 (8), p.1417-1424

2021

Volltextzugriff (PDF)

Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes

Journal of diabetes investigation, 2019-03, Vol.10 (2), p.429-438

2019

Volltextzugriff (PDF)

Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo

Journal of neuroscience research, 2007-05, Vol.85 (7), p.1528-1537

2007

Volltextzugriff (PDF)

Environmental reputation and bank liquidity: Evidence from climate transition

Journal of business finance & accounting, 2023-07, Vol.50 (7-8), p.1274-1304

2023

Volltextzugriff (PDF)

R&D investment decisions in business groups: Evidence from a natural experiment

Corporate governance : an international review, 2022-01, Vol.30 (1), p.55-79

2022

Volltextzugriff (PDF)

Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: An analysis using nationwide Korea Liver Cancer Registry Database

HPB (Oxford, England), 2019, Vol.21, p.S241-S241

2019

Volltextzugriff (PDF)

Tumor marker-based risk assessment of hepatocellular carcinoma recurrence after liver transplantation

HPB (Oxford, England), 2019, Vol.21, p.S283-S283

2019

Volltextzugriff (PDF)

Animal Model for Alzheimer's Disease by PS2 Gene Transfer

Annals of the New York Academy of Sciences, 2001-04, Vol.928 (1), p.351-351

2001

Volltextzugriff (PDF)

Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo

Journal of neuroscience research, 2007-05, Vol.85 (7), p.1528-1537

2007

Volltextzugriff (PDF)

Inhibition of Mast Cell‐Dependent Anaphylaxis by Succinic Acid

Pharmacology & toxicology, 1999-04, Vol.84 (4), p.154-158

1999

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(13)
Female
(12)
Male
(12)
Middle Aged
(11)
Diabetes
(10)
Diabetes Mellitus
(10)
Endocrinology & Metabolism
(10)
Glucose
(9)
Diabetes Mellitus, Type 2 - Drug Therapy
(8)
Hemoglobin
(8)
Type 2 Diabetes
(8)
Antidiabetics
(7)
Aged
(6)
Blood Glucose - Analysis
(6)
Glycosylated Hemoglobin
(6)
Insulin
(6)
Pharmaceutical Industry
(6)
Prospective Studies
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patchouli Alcohol Possesses Anti‐Inflammatory Activity in RAW264.7 and HT‐29 cells

Role of rice cytosolic hexokinase OsHXK7 in sugar signaling and metabolism

Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone

Splenic devascularization can replace splenectomy during adult living donor liver transplantation – a historical cohort study

An analysis of vascular properties using pulse wave analysis in patients with vasovagal syncope

Mechanical and Pharmacological Revascularization Strategies for Prevention of Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction: Analysis from Index of Microcirculatory Resistance Registry Data

Effect of switching from pioglitazone to the sodium glucose co‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus: An open‐label, prospective, randomized, parallel‐group comparison trial

Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial

Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)

Splenic devascularization can replace splenectomy during adult living donor liver transplantation – a historical cohort study

Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea

Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial

Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin

Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study

Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes

Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo

Environmental reputation and bank liquidity: Evidence from climate transition

R&D investment decisions in business groups: Evidence from a natural experiment

Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: An analysis using nationwide Korea Liver Cancer Registry Database

Tumor marker-based risk assessment of hepatocellular carcinoma recurrence after liver transplantation

Animal Model for Alzheimer's Disease by PS2 Gene Transfer

Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo

Inhibition of Mast Cell‐Dependent Anaphylaxis by Succinic Acid

Aktive Filter

Suchergebnisse filtern